Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
Clinical trial NCT05819892 · RECRUITING
Trial details
- NCT number
- NCT05819892
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-17
- Primary completion
- 2027-03-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.